BMJ10h
Treatment of atrial fibrillation
Department of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands Professor H J G M Crijns, Maastricht University Medical Center, Department of Cardiology, Postbus 5800, 6202 ...
BMJ14h
Different responses to dobutamine in the presence of carvedilol or metoprolol in patients with chronic heart failure
Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska University Hospital, Göteborg, Sweden Correspondence to: Dr Bert Andersson, Wallenberg Laboratory, Sahlgrenska University Hospital, 413 ...
BMJ23h
Patients’ beliefs about their cardiovascular disease
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
BMJ1d
Motor vehicle crash risk after cardioverter-defibrillator implantation: a population-based cohort study
Background Limited empirical evidence informs driving restrictions after implantable cardioverter-defibrillator (ICD) ...
BMJ3d
Exercise training improves cardiovascular fitness in dilated cardiomyopathy caused by truncating titin variants
Background Participation in regular exercise activities is recommended for patients with chronic heart failure. However, less ...
BMJ4d
Percutaneous revascularisation in chronic coronary syndromes: when real-world data unveil the other side of the coin
The optimal treatment of chronic coronary syndromes (CCS) represents to date a matter of debate as revascularisation has not ...
BMJ8d
Optimising remote monitoring for cardiac implantable electronic devices: a UK Delphi consensus
Background Remote monitoring (RM) is recommended for the ongoing management of patients with cardiac implantable electronic devices (CIEDs). Despite its benefits, RM adoption has increased the ...
BMJ14d
Management strategies and outcomes in pregnancy-related acute aortic dissection: a multicentre cohort study in China
Background Acute aortic dissection (AD) in pregnancy poses a lethal risk to both mother and fetus. However, well-established therapeutic guidelines are lacking. This study aimed to investigate ...
BMJ15d
Predicting future atrial fibrillation: risk factors, proteomics and beyond
The term ‘epidemic’ is increasingly used to describe the rising global prevalence of atrial fibrillation (AF). Recent estimates suggest that AF accounts for between 0.9% and 1.6% of total healthcare ...
BMJ20d
Health, burnout and well-being of UK cardiology trainees: insights from the British Junior Cardiologists’ Association Survey
Background Cardiology training is demanding and associated with high workloads. Poor lifestyle and health among clinicians may stretch workforces and impact patient care. It has not been established ...
BMJ22d
Enhanced prediction of atrial fibrillation risk using proteomic markers: a comparative analysis with clinical and polygenic risk scores
Background Proteomic biomarkers have shown promise in predicting various cardiovascular conditions, but their utility in assessing the risk of atrial fibrillation (AF) remains unclear. This study ...
BMJ29d
Universal definition of myocardial infarction: what must we know? What is next?
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...